CARDOZA GEORGE 4
4 · NEOGENOMICS INC · Filed Dec 30, 2021
Insider Transaction Report
Form 4
CARDOZA GEORGE
Chief Financial Officer
Transactions
- Award
Common Stock
2021-12-30+61,143→ 245,499 total
Holdings
- 20,000(indirect: By Trust)
Common Stock
- 50,000
Stock Option (Right to Buy)
Exercise: $7.52Exp: 2022-04-28→ Common Stock (50,000 underlying) - 51,459
Stock Option (Right to Buy)
Exercise: $19.60Exp: 2024-03-01→ Common Stock (51,459 underlying) - 35,171
Stock Option (Right to Buy)
Exercise: $53.17Exp: 2028-03-02→ Common Stock (35,171 underlying) - 40,502
Stock Option (Right to Buy)
Exercise: $43.95Exp: 2028-07-05→ Common Stock (40,502 underlying) - 192,500
Stock Option (Right to Buy)
Exercise: $8.03Exp: 2023-02-26→ Common Stock (192,500 underlying) - 48,768
Stock Option (Right to Buy)
Exercise: $28.33Exp: 2027-03-02→ Common Stock (48,768 underlying)
Footnotes (7)
- [F1]On December 30, 2021, Mr. Cardoza was granted 61,143 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022.
- [F2]On April 28, 2017, Mr. Cardoza was granted 200,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
- [F3]On February 26, 2018, Mr. Cardoza was granted 192,500 stock options. These options vested ratably over the first three anniversary dates of the grant date.
- [F4]On March 1, 2019, Mr. Cardoza was granted 51,459 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F5]On March 2, 2020, Mr. Cardoza was granted 48,768 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F6]On March 2, 2021, Mr. Cardoza was granted 35,171 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F7]On July 5, 2021, Mr. Cardoza was granted 40,502 stock options. These options vest ratably over the first four anniversary dates of the grant date.